Survey to Evaluate the Effectiveness of Risk Minimisation Measures for Atezolizumab Use in the European Union First published 07/12/2017 Last updated 02/07/2024 EU PAS number:EUPAS21920 Study Finalised
OXON Epidemiology Spain United Kingdom First published:06/12/2010 Last updated 15/03/2024 Institution Laboratory/Research/Testing facility Non-Pharmaceutical company ENCePP partner
Flavia Di Nucci global.clinical_trial_registry@roche.comStudy contactglobal.clinical_trial_registry@roche.com